Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2400 of 3546 entries
View as:

A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01568749 Org: User:
Start: 12/31/08 End: 08/31/09 Due: 08/31/10

Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00078572 Org: User:
Start: 03/31/04 End: 02/28/10 Due: 02/28/11

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01235949 Org: User:
Start: 11/12/10 End: 12/08/12 Due: 12/08/13

Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00324961 Org: User:
Start: 01/31/06 End: 01/31/09 Due: 01/31/10

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Phase: N/A Priority: Normal
NCT ID: NCT02287688 Org: User:
Start: 12/01/14 End: 11/29/17 Due: 11/29/18

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT01148459 Org: User:
Start: 07/30/10 End: 05/24/13 Due: 05/24/14

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Phase: N/A Priority: Normal
NCT ID: NCT04719832 Org: User:
Start: 03/17/21 End: 11/21/23 Due: 11/21/24

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00376038 Org: User:
Start: 08/31/06 End: 10/31/06 Due: 10/31/07

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02612051 Org: User:
Start: 12/04/15 End: 06/02/16 Due: 06/02/17

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT01134042 Org: User:
Start: 06/30/10 End: 10/31/11 Due: 10/31/12

Study of GW685698X In Patients With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00363740 Org: User:
Start: 02/19/05 End: 04/13/05 Due: 04/13/06

Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03034967 Org: User:
Start: 04/25/17 End: 10/05/18 Due: 10/05/19

An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00358410 Org: User:
Start: 01/31/06 End: 08/31/06 Due: 08/31/07

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive

Phase: N/A Priority: Normal
NCT ID: NCT05590338 Org: User:
Start: 11/04/22 End: 12/28/23 Due: 12/28/24

Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children

Phase: N/A Priority: Normal
NCT ID: NCT01031082 Org: User:
Start: 05/31/09 End: 05/31/10 Due: 05/31/11

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00258700 Org: User:
Start: 02/28/05 End: 07/31/06 Due: 07/31/07

Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children

Phase: N/A Priority: Normal
NCT ID: NCT00474266 Org: User:
Start: 06/05/07 End: 03/26/08 Due: 03/26/09

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Phase: N/A Priority: Normal
NCT ID: NCT00839254 Org: User:
Start: 02/18/09 End: 01/31/12 Due: 01/31/13

Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Phase: N/A Priority: Normal
NCT ID: NCT03069989 Org: User:
Start: 06/13/17 End: 07/18/18 Due: 07/18/19

A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03015519 Org: User:
Start: 08/14/17 End: 04/20/20 Due: 04/20/21

BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00839397 Org: User:
Start: 05/31/02 End: 06/30/05 Due: 06/30/06

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04138043 Org: User:
Start: 12/05/19 End: 05/28/20 Due: 05/28/21

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02152605 Org: User:
Start: 09/01/14 End: 03/05/15 Due: 03/05/16

Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B

Phase: N/A Priority: Normal
NCT ID: NCT00698087 Org: User:
Start: 01/31/95 End: 02/29/96 Due: 02/28/97

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

Phase: N/A Priority: Normal
NCT ID: NCT00792623 Org: User:
Start: 09/08/03 End: 09/10/07 Due: 09/10/08